NASDAQ:CMPX

Compass Therapeutics Stock Predictions

etoro logo Buy CMPX
*Your capital is at risk
$2.10
+0.0200 (+0.96%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CMPX Prediction Chart

CMPX Predictions History

Latest community submissions for CMPX.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 21, 2025 $4.16 +2.82% $4.10 V 98.43% 1
Oct 21, 2025 $4.12 +1.76% $4.10 V 99.48% 4
Oct 21, 2025 $4.60 +13.58% $4.10 V 87.80% 1
Oct 20, 2025 $4.37 +2.63% $4.05 X 92.05% 0
Oct 20, 2025 $4.33 +1.64% $4.05 X 93.09% 0
Oct 20, 2025 Bullish $4.05 X 0
Oct 8, 2025 $3.52 -2.46% $3.90 X 90.28% 0
Oct 8, 2025 $3.55 -1.54% $3.90 X 91.14% 0
Oct 8, 2025 Bullish $3.90 V 1
Oct 6, 2025 $3.61 -2.37% $3.67 V 98.43% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CMPX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT COMPASS THERAPEUTICS, INC.
Compass Therapeutics
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops proprietary antibody-based therapeutics to treat multiple human diseases. The company's product candidates include CTX-009, an investigational bispecific antibody, which is in Phase II clinical trial for biliary tract cancers, as well as Phase Ib clinical trial for colorectal and ovarian cancer; CTX-471, a monoclonal antibody product candidate that i...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE